Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
UK Announces Labeling Guides
New guidelines for the design of drug labeling and packaging, aimed at reducing medication error, were announced March 3 by Britain's Health Minister, Lord Philip Hunt.
The Best Practice Guidance Document, published March 3, sets out what factors should be considered when designing drug-package labeling. These include layout, size of text, and colors used. In addition, although 15 different pieces of information are legally required to appear on a label, users need rapid access to only five key pieces of critical information ' the name of the medicine, strength, route of administration, dosage, and warnings. The guidance advises that these should be brought together on the pack for ease of access. This guidance will be used in the future by industry when designing labeling and packaging for medicines and will assist in preventing medication errors in practice. A copy of the full guidance document is available at http://www.mca.gov.uk/
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The DOJ's New Parameters for Evaluating Corporate Compliance Programs
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
Use of Deferred Prosecution Agreements In White Collar Investigations
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Compliance Officers: Recent Regulatory Guidance and Enforcement Actions and Mitigating the Risk of Personal Liability
This article explores legal developments over the past year that may impact compliance officer personal liability.